PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biomedical Systems Laboratory, National Technical University of Athens, Athens, Greece.\', \'ProtATonce Ltd, Demokritos Science Park, Athens, Greece.\', \'Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece.\', \'Division of Infectious Diseases, Department of Internal Medicine, University Hospital of Patras, Patras, Greece.\', \'Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.\', \'Medicinal Microbiology Laboratory, Hellenic Pasteur Institute, Athens, Greece.\', \'Pharmacology Laboratory, University of Patras, Patras, Greece.\', \'National Public Health Organization, Athens, Greece.\', \'Department of Internal Medicine, BMT Unit and CBMDP Donor Center, University of Patras, Patras, Greece. spyridonidis@upatras.gr.\', \'Biomedical Systems Laboratory, National Technical University of Athens, Athens, Greece. leo@mail.ntua.gr.\', \'ProtATonce Ltd, Demokritos Science Park, Athens, Greece. leo@mail.ntua.gr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-86035-2
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33758278
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all